30 Apr 2024
18:45 CEST |
EQUASENS |
EQUASENS : Modalités de mise à disposition de l'URD 2023
|
10101015 Software |
Income |
29 Mar 2024
18:02 CET |
EQUASENS |
EQUASENS : Résultats Annuels 2023
|
10101015 Software |
Income |
29 Mar 2024
18:02 CET |
EQUASENS |
Equasens: 2023 Annual Results
|
10101015 Software |
Income |
07 Feb 2024
18:30 CET |
EQUASENS |
EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE
|
10101015 Software |
Other subject |
06 Feb 2024
18:00 CET |
EQUASENS |
EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€
|
10101015 Software |
Sales |
06 Feb 2024
18:00 CET |
EQUASENS |
Equasens: 2023 revenue: €219.7m, +2.6%
|
10101015 Software |
Sales |
02 Jan 2024
18:00 CET |
EQUASENS |
EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
02 Jan 2024
18:00 CET |
EQUASENS |
Equasens: Acquisition of a majority stake in DIGIPHARMACIE
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
27 Dec 2023
18:00 CET |
EQUASENS |
EQUASENS : Evolution du Comité de Direction du Groupe Equasens
|
10101015 Software |
Journal / appointments |
27 Dec 2023
18:00 CET |
EQUASENS |
Equasens: Changes in the Equasens Group Executive Committee
|
10101015 Software |
Journal / appointments |
23 Nov 2023
18:00 CET |
EQUASENS |
EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
23 Nov 2023
18:00 CET |
EQUASENS |
EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
09 Nov 2023
18:00 CET |
EQUASENS |
Equasens: Q3 2023 revenue
|
10101015 Software |
Sales |
09 Nov 2023
18:00 CET |
EQUASENS |
EQUASENS : Chiffre d’affaires du 3ème trimestre 2023
|
10101015 Software |
Sales |
04 Oct 2023
18:06 CEST |
EQUASENS |
EQUASENS : Mise à disposition du Rapport Financier Semestriel 2023
|
10101015 Software |
Income |
29 Sep 2023
18:00 CEST |
EQUASENS |
EQUASENS : Résultats Semestriels 2023
|
10101015 Software |
Income |
29 Sep 2023
18:00 CEST |
EQUASENS |
EQUASENS: H1 2023 Results
|
10101015 Software |
Income |
25 Sep 2023
18:00 CEST |
EQUASENS |
EQUASENS : bilan du contrat de liquidité au 30 juin 2023
|
10101015 Software |
Other subject |
03 Aug 2023
18:00 CEST |
EQUASENS |
EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m
|
10101015 Software |
Sales |
03 Aug 2023
18:00 CEST |
EQUASENS |
GROUPE EQUASENS : Chiffre d’affaires du 1er semestre 2023 en progression de 9 % à 112,62 M€
|
10101015 Software |
Sales |
05 Jul 2023
18:00 CEST |
EQUASENS |
EQUASENS : résultat du vote des résolutions présentées à l’assemblée générale ordinaire annuelle du 29 juin 2023
|
10101015 Software |
General meeting / Board Meeting |
05 Jul 2023
18:00 CEST |
EQUASENS |
EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023
|
10101015 Software |
General meeting / Board Meeting |
09 Jun 2023
18:00 CEST |
EQUASENS |
EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES
|
10101015 Software |
General meeting / Board Meeting |
09 Jun 2023
18:00 CEST |
EQUASENS |
EQUASENS: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS
|
10101015 Software |
General meeting / Board Meeting |
11 May 2023
18:00 CEST |
EQUASENS |
EQUASENS : Chiffre d’affaires T1 2023 : +13,96% à 56,25 M€
|
10101015 Software |
Sales |
11 May 2023
18:00 CEST |
EQUASENS |
EQUASENS: Q1 2023 revenue: +13.96% to €56.25m
|
10101015 Software |
Sales |
04 May 2023
12:00 CEST |
EQUASENS |
EQUASENS : Mise à disposition du Document d’Enregistrement Universel 2022
|
10101015 Software |
Other subject |
06 Apr 2023
18:00 CEST |
EQUASENS |
EQUASENS : Atoopharm, le spécialiste e-learning de la formation officinale, rejoint le Groupe Equasens.
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
03 Apr 2023
07:00 CEST |
EQUASENS |
EQUASENS : Acquisitions de Pratilog et Speech2Sense
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
24 Mar 2023
18:00 CET |
EQUASENS |
EQUASENS : Résultat Net 2022 : +18,35% à 48,70 M€
|
10101015 Software |
Income |
24 Mar 2023
18:00 CET |
EQUASENS |
EQUASENS: 2022 Net Profit: +18.35% to €48.70m
|
10101015 Software |
Income |
03 Feb 2023
18:00 CET |
EQUASENS |
EQUASENS : CA 2022 : +10,88% à 214,07 M€
|
10101015 Software |
Sales |
03 Feb 2023
18:00 CET |
EQUASENS |
EQUASENS: FY 2022 revenue: +10.88% to €214.07m
|
10101015 Software |
Sales |
20 Jan 2023
18:00 CET |
EQUASENS |
EQUASENS : BILAN SEMESTRIEL S2-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC GILBERT DUPONT
|
10101015 Software |
Share history |
20 Jan 2023
18:00 CET |
EQUASENS |
EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT
|
10101015 Software |
Share history |
19 Jan 2023
18:00 CET |
EQUASENS |
EQUASENS: Appointment of Frédérique SCHMIDT as the Group’s Chief Administrative and Financial Officer
|
10101015 Software |
Journal / appointments |
19 Jan 2023
18:00 CET |
EQUASENS |
EQUASENS : Nomination de Frédérique SCHMIDT en tant que Directrice Administrative et Financière du Groupe
|
10101015 Software |
Journal / appointments |
09 Nov 2022
18:00 CET |
EQUASENS |
EQUASENS GROUP: 2022 third-quarter revenue
|
10101015 Software |
Sales |
09 Nov 2022
18:00 CET |
EQUASENS |
GROUPE EQUASENS : Chiffre d’affaires du 3ème trimestre 2022
|
10101015 Software |
Sales |
18 Oct 2022
18:00 CEST |
EQUASENS |
EQUASENS: subsidiary PANDALAB receives ISO 27001 and HDS certifications
|
10101015 Software |
Corporate life |
18 Oct 2022
18:00 CEST |
EQUASENS |
EQUASENS : sa filiale PANDALAB certifié ISO 27001 et HDS
|
10101015 Software |
Corporate life |
30 Sep 2022
18:00 CEST |
EQUASENS |
EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2022
|
10101015 Software |
Income |
22 Sep 2022
18:00 CEST |
EQUASENS |
EQUASENS: H1 2022 Results
|
10101015 Software |
Income |
22 Sep 2022
18:00 CEST |
EQUASENS |
EQUASENS : Résultats Semestriels 2022
|
10101015 Software |
Income |
03 Aug 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex-Pharmagest Interactive): H1 2022 Revenue
|
10101015 Software |
Sales |
03 Aug 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex-PHARMAGEST INTERACTIVE) : Chiffre d’affaires du 1er semestre 2022
|
10101015 Software |
Sales |
28 Jul 2022
18:00 CEST |
EQUASENS |
Equasens Group (ex Pharmagest Interactive): Complition of three majority acquisitions
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
28 Jul 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex - PHARMAGEST INTERACTIVE) : Le Groupe complète 3 prises de participation majoritaire
|
10101015 Software |
Mergers, Acquiqitions, Transferts |
21 Jul 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT
|
10101015 Software |
Other subject |
21 Jul 2022
18:00 CEST |
EQUASENS |
EQUASENS (ex PHARMAGEST INTERACTIVE) : BILAN SEMESTRIEL S1-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT
|
10101015 Software |
Other subject |